[144] Lennox International Inc. SEC Filing

Rhea-AI Filing Summary

UiPath, Inc. (PATH) – Form 144 filing

ICE Vulcan Holding Limited, which originally received founder shares on 04/21/2021, has notified the SEC of its intent to sell up to 1,000,000 Class A common shares through Morgan Stanley Smith Barney on or after 07/23/2025. At the filing’s reference price of $12.59, the block is valued at $12.59 million and equals roughly 0.22 % of UiPath’s 457.6 million shares outstanding.

The notice also details an active Rule 10b5-1 program: over the past three months the same holder executed ≈1.97 million share sales across 45 transactions, generating about $27.8 million in gross proceeds. No operating or financial metrics are provided; the signatory attests that no undisclosed material information exists.

While the proposed sale is modest relative to the float, continuing insider distribution may add incremental supply pressure and warrants monitoring by investors.

Positive

• Transparent disclosure via timely Form 144 and Rule 10b5-1 plan signals adherence to insider-trading safeguards.

Negative

• Additional 1 million shares (0.22 % of float) set to hit the market, adding to ≈1.97 million shares already sold in prior three months.
• Ongoing insider sales may pressure short-term share price and influence investor sentiment.

Insights

Equity Analyst

TL;DR: Modest but steady insider selling; neutral-to-slightly negative for near-term sentiment.

The 1 million-share Form 144 equals just 0.22 % of outstanding shares, yet follows nearly 2 million shares sold in the prior quarter under a 10b5-1 plan. Aggregate insider supply of almost 3 million shares (~0.65 % of float) in four months could weigh on short-term trading, especially given PATH’s historically high float turnover. The filing contains no business updates, so valuation fundamentals remain unchanged; however, persistent distribution by a founding holder typically signals portfolio rebalancing rather than corporate weakness. Overall impact is limited but directionally negative for momentum-focused investors.

Corporate Governance Specialist

TL;DR: Filing follows Rule 144 & 10b5-1 protocols, indicating procedural compliance.

The seller disclosed the sale in advance, used a well-established broker, and referenced a pre-arranged 10b5-1 plan—hallmarks of strong governance and transparency. The representation that no material non-public information is held further mitigates insider-trading risk. Frequency of sales suggests disciplined diversification rather than abrupt exit. From a governance viewpoint, the event is routine and non-impactful.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	22329	13843310.13	35124281	07/23/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/23/2009	Gift	John W. Norris, Jr.		07/23/2009	22329		NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JOHN W NORRIS III 2140 LAKE PARK BLVD. RICHARDSON TX 75080	Common	07/10/2025	3190	1957772.22
10b5-1 Sales for JOHN W NORRIS III 2140 LAKE PARK BLVD. RICHARDSON TX 75080	Common	07/03/2025	3190	1933140.00
10b5-1 Sales for JOHN W NORRIS III 2140 LAKE PARK BLVD. RICHARDSON TX 75080	Common	07/01/2025	3190	1914000.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many UiPath (PATH) shares are being registered for sale?

The Form 144 covers 1,000,000 Class A common shares.

What is the estimated market value of the proposed sale?

At $12.59 per share, the block is valued at $12.59 million.

When could the insider begin selling the shares?

The approximate sale date listed is 07/23/2025 on the NYSE.

How significant is the sale relative to UiPath’s share count?

The filing represents about 0.22 % of the 457.6 million shares outstanding.

Were there other recent insider sales?

Yes. The same holder sold ≈1.97 million shares over the last three months under a Rule 10b5-1 program.